- Albemarle’s net sales for 4Q reached $2.36 billion, beating the estimated $2.17 billion.
- However, there was a 10% decline in net sales year-on-year.
- The company reported an adjusted Ebitda loss of $315.0 million, a significant downturn from the profit of $1.24 billion it made the previous year.
- The estimated profit for this period was $221.6 million, which Albemarle failed to meet.
- Looking ahead, Albemarle predicts its capital expenditures for 2024 to fall between $1.6 billion and $1.8 billion.
- This is a decrease from the $2.1 billion spent in 2023.
- Albemarle’s stocks currently stand at 21 buys, 9 holds, and 2 sells.
Albemarle Corp on Smartkarma
Albemarle Corp has been getting a lot of attention from top independent analysts on Smartkarma, an independent investment research network. Brian Freitas has published a bullish insight report on the company, stating that Albemarle will replace ioneer in the VanEck Rare Earth/Strategic Metals Index, resulting in an estimated one-way turnover of 13.4% and a one-way trade of US$50m. This change will also reduce the weight of mainland China stocks in the index significantly.
Baptista Research, another provider on Smartkarma, has also published two bullish reports on Albemarle Corp. The first report discusses the potential game-changing acquisition of Liontown and the company’s recent financial results, which saw a decline in net income and diluted earnings per share despite an increase in sales. The second report highlights Albemarle’s positive performance in the last quarter, with an all-around beat in net sales and EBITDA. Based on their analysis, Baptista Research has given Albemarle Corp a ‘Buy’ rating with a revised target price.
A look at Albemarle Corp Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 2 | |
| Growth | 5 | |
| Resilience | 3 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Albemarle Corp, a producer of specialty and fine chemicals, has a positive long-term outlook according to the Smartkarma Smart Scores. The company has received a score of 4 for value, indicating that it is considered a good value in the market. This suggests that investors may see potential for growth in the company’s stock.
Additionally, Albemarle Corp has scored a 5 for growth, indicating that it is expected to see strong growth in the future. This is likely due to the company’s diverse range of products, which are used in various industries such as plastics, cleaning products, and pharmaceuticals. With a score of 3 for resilience, the company is also expected to weather potential market challenges.
However, the company has received a lower score of 2 for both dividend and momentum. This suggests that while Albemarle Corp may not be a strong choice for investors seeking immediate returns, it has potential for long-term growth and stability. With a majority of its products produced in the United States, Albemarle Corp is well-positioned to continue its success in the industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars
